$CSLR
Complete Solaria, Inc. Stock $cslr

$cslr Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000121390023027997 Filed on April 06, 2023

Income Statement

Concept	2022 Q4	2022	2021
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue		$46.65M	$40.12M
YoY Change		16.26%	134.68%
Gross Profit		$19.83M	$28.69M
YoY Change		-30.9%	133.64%
Gross Profit Margin
Selling, General & Admin	$681.8K	$6.156M	$5.179M
YoY Change		18.86%	62.61%
% of Gross Profit		31.05%	18.05%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$2.580M	$4.407M	$3.780M
YoY Change		16.59%	37700.0%
Operating Profit		-$4.407M	-$3.782M
YoY Change		16.53%	-26.06%
Interest Expense	$2.801M	$4.804M	$100.0K
YoY Change		4703.99%	-80.88%
% of Operating Profit
Other Income/Expense, Net	-$1.236M	$10.39M	$8.810M
YoY Change		17.93%	-21587.8%
Pretax Income	-$743.8K	$5.982M	$5.130M
YoY Change		16.61%	-51400.0%
Income Tax		$27.00K	$3.000K
% Of Pretax Income		0.45%	0.06%
Net Earnings	-$743.8K	$5.982M	$5.130M
YoY Change		16.61%	-51400.0%
Net Earnings / Revenue
Basic Earnings Per Share		-$1.31	-$0.77
Diluted Earnings Per Share	-$0.02	$0.14	$137.6K
COMMON SHARES
Basic Shares Outstanding		22.52M	11.99M
Diluted Shares Outstanding		22.52M	11.99M

Balance Sheet

Concept	2022 Q4	2022	2021
SHORT-TERM ASSETS
Cash & Short-Term Investments	$72.92K	$72.92K	$300.0K
YoY Change		-75.69%
Cash & Equivalents	$72.92K
Short-Term Investments
Other Short-Term Assets	$120.7K	$120.7K	$700.0K
YoY Change		-82.76%	600.0%
Inventory	$13.06M
Prepaid Expenses	$120.7K
Receivables	$27.72M
Other Receivables
Total Short-Term Assets	$193.6K	$193.6K	$1.000M
YoY Change	-80.67%	-80.64%	900.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.476M
YoY Change	97.72%
Goodwill
YoY Change
Intangibles	$42.61M
YoY Change
Long-Term Investments	$349.9M	$349.9M	$345.1M
YoY Change		1.4%
Other Assets	$0.00	$0.00	$100.0K
YoY Change		-100.0%
Total Long-Term Assets	$349.9M	$349.9M	$345.2M
YoY Change	1.36%	1.37%
TOTAL ASSETS
Total Short-Term Assets	$193.6K	$193.6K	$1.000M
Total Long-Term Assets	$349.9M	$349.9M	$345.2M
Total Assets	$350.1M	$350.1M	$346.2M
YoY Change	1.13%	1.13%	346100.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.858M	$4.858M	$2.600M
YoY Change		86.85%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$828.6K	$828.6K	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.687M	$5.687M	$2.600M
YoY Change	120.45%	118.72%	2500.0%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$5.997M	$5.997M	$20.60M
YoY Change		-70.89%
Total Long-Term Liabilities	$5.997M	$5.997M	$20.60M
YoY Change		-70.89%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.687M	$5.687M	$2.600M
Total Long-Term Liabilities	$5.997M	$5.997M	$20.60M
Total Liabilities	$11.68M	$11.68M	$23.10M
YoY Change	-49.51%	-49.42%	23000.0%
SHAREHOLDERS EQUITY
Retained Earnings	-$17.55M
YoY Change	-19.95%
Common Stock	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$11.49M	$338.4M	$323.1M
YoY Change
Total Liabilities & Shareholders Equity	$350.1M	$350.1M	$346.2M
YoY Change	1.13%	1.13%	346100.0%

Cashflow Statement

Concept	2022 Q4	2022	2021
OPERATING ACTIVITIES
Net Income	-$743.8K	$5.982M	$5.130M
YoY Change		16.61%	-51400.0%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$321.6K	-$1.430M	-$2.040M
YoY Change		-29.92%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions		-$4.848M
YoY Change
Other Investing Activities	$0.00	$0.00	-$345.0M
YoY Change		-100.0%
Cash From Investing Activities	$0.00		-$345.0M
YoY Change			58975.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		-$18.60M	$348.0M
YoY Change		-105.35%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	225.0K	$1.225M	347.3M
YoY Change		-99.65%	5365.3%
NET CHANGE
Cash From Operating Activities	-321.6K	-$1.430M	-2.040M
Cash From Investing Activities	0.000		-345.0M
Cash From Financing Activities	225.0K	$1.225M	347.3M
Net Change In Cash	-96.63K	-$204.7K	280.0K
YoY Change		-173.09%
FREE CASH FLOW
Cash From Operating Activities	-$321.6K	-$1.430M	-$2.040M
Capital Expenditures
Free Cash Flow		-$1.430M
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent		usd
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent		usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-40117
CY2022	dei	Entity Registrant Name EntityRegistrantName	FREEDOM ACQUISITION I CORP.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	14 Wall Street
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	20th Floor
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10005
CY2022	dei	City Area Code CityAreaCode	212
CY2022	dei	Local Phone Number LocalPhoneNumber	618-1798
CY2022	dei	Security12b Title Security12bTitle	Class A ordinary shares, par value $0.0001 per share
CY2022	dei	Trading Symbol TradingSymbol	FACT
CY2022	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	true
CY2022Q2	dei	Entity Public Float EntityPublicFloat	339256450	usd
CY2022	dei	Auditor Firm AuditorFirmId	688
CY2022	dei	Auditor Name AuditorName	Marcum llp
CY2022	dei	Auditor Location AuditorLocation	New York, NY
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	72923	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	277583	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	120677	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	724066	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	193600	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1001649	usd
CY2021Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	113073	usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	349927313	usd
CY2021Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	345105681	usd
CY2022Q4	us-gaap	Assets Assets	350120913	usd
CY2021Q4	us-gaap	Assets Assets	346220403	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4858215	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2579641	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	828600	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5686815	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2579641	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	2978333	usd
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	8488250	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	3018750	usd
CY2021Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	12075000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	11683898	usd
CY2021Q4	us-gaap	Liabilities Liabilities	23142891	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	349927313	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	345000000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	fact	Common Stock Value One CommonStockValueOne	863	usd
CY2021Q4	fact	Common Stock Value One CommonStockValueOne	863	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6057438	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17548599	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-21923351	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-11490298	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-21922488	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	350120913	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	346220403	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	4407058	usd
CY2021	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	3782028	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-4407058	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-3782028	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-17638	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1475	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	4821632	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	105681	usd
CY2022	fact	Partial Reversal Of Transaction Costs PartialReversalOfTransactionCosts	271687	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-5509917	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-9381750	usd
CY2022	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-196200	usd
CY2021	us-gaap	Noninterest Expense Offering Cost NoninterestExpenseOfferingCost	575278	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	10389398	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	8910678	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	5982340	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	5128650	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	19506	usd
CY2021	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	34500000	shares
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3450	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1880000	usd
CY2021	us-gaap	Stockholders Equity Other StockholdersEquityOther	-3450	usd
CY2021	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-28950644	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	5128650	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-21922488	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	592600	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-592600	usd
CY2022	us-gaap	Stock Issued During Period Value Treasury Stock Reissued StockIssuedDuringPeriodValueTreasuryStockReissued	-4334713	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	8784563	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	5982340	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-11490298	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	5982340	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	5128650	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	4821632	usd
CY2021	us-gaap	Interest Income Other InterestIncomeOther	105681	usd
CY2022	fact	Change In Fair Value Of Warrant Liabilities ChangeInFairValueOfWarrantLiabilities	-5509917	usd
CY2021	fact	Change In Fair Value Of Warrant Liabilities ChangeInFairValueOfWarrantLiabilities	-9381750	usd
CY2022	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-196200	usd
CY2022	fact	Change In Deferred Underwriting Fee ChangeInDeferredUnderwritingFee	-271687	usd
CY2021	fact	Offering Costs Allocated To Warrants OfferingCostsAllocatedToWarrants	-575278	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-716462	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	837139	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2278574	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2579641	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1429660	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2041001	usd
CY2021	fact	Cash Deposited In Trust Account CashDepositedInTrustAccount	-345000000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-345000000	usd
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	338595000	usd
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	9400000	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1225000	usd
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	90996	usd
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	585420	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1225000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	347318584	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-204660	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	277583	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	277583	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	72923	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	277583	usd
CY2021	fact	Initial Value Of Class A Ordinary Share Subject To Possible Redemption InitialValueOfClassAOrdinaryShareSubjectToPossibleRedemption	345000000	usd
CY2021	fact	Initial Value Of Warrant Liabilities InitialValueOfWarrantLiabilities	17870000	usd
CY2021	fact	Deferred Offering Costs Included In Accrued Expenses DeferredOfferingCostsIncludedInAccruedExpenses	12075000	usd
CY2022	fact	Accretion Of Class A Ordinary Shares Subject To Possible Redemptionin Shares AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares	4927313	usd
CY2021	fact	Accretion Of Class A Ordinary Shares Subject To Possible Redemptionin Shares AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares	28950644	usd
CY2021	fact	Deferred Offering Costs Paid Under Promissory Note DeferredOfferingCostsPaidUnderPromissoryNote	90996	usd
CY2022	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	6405000	usd
CY2022	fact	Deferred Underwriting Fee DeferredUnderwritingFee	12075000	usd
CY2022Q4	us-gaap	Other Ownership Interests Offering Costs OtherOwnershipInterestsOfferingCosts	695922	usd
CY2022	fact	Total Transaction Cost TotalTransactionCost	575278	usd
CY2022	fact	Net Tangible Assets NetTangibleAssets	5000001	usd
CY2022	fact	Redeem Public Shares Percentage RedeemPublicSharesPercentage	1	pure
CY2022Q4	fact	Public Per Share PublicPerShare	10
CY2022Q4	fact	Trust Account Per Share TrustAccountPerShare	10
CY2022Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	72923	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	4821632	usd
CY2022Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.01	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.01	pure
CY2022Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	205869	usd
CY2022Q3	fact	Operational Costs OperationalCosts	205869	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Use of Estimates</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The preparation of the consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Estimates made in preparing these consolidated financial statements include, among other things, the fair value measurement of the Private Warrant liabilities.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2022Q4	us-gaap	Cash Cash	349927313	usd
CY2021Q4	us-gaap	Cash Cash	484	usd
CY2022Q4	fact	Trading Securities Fair Value TradingSecuritiesFairValue	349927313	usd
CY2021Q4	fact	Amortized Cost And Carrying Value AmortizedCostAndCarryingValue	345105681	usd
CY2021	fact	Gross Unrealized Gains And Losses GrossUnrealizedGainsAndLosses	-6065	usd
CY2021Q4	fact	Trading Securities Fair Value TradingSecuritiesFairValue	345099616	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Concentration of Credit Risk </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At December 31, 2022 and 2021, the Company has not experienced losses on this account. </p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022	fact	Warrants Purchase WarrantsPurchase	14891667	shares
CY2021	fact	Warrants Purchase WarrantsPurchase	14891667	shares
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	19175922	usd
CY2022	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	6405000	usd
CY2022	fact	Deferred Underwriting Fee DeferredUnderwritingFee	12075000	usd
CY2022Q4	us-gaap	Other Ownership Interests Offering Costs OtherOwnershipInterestsOfferingCosts	695922	usd
CY2022	fact	Total Transaction Cost TotalTransactionCost	575278	usd
CY2022	us-gaap	Expense Related To Distribution Or Servicing And Underwriting Fees ExpenseRelatedToDistributionOrServicingAndUnderwritingFees	9056250	usd
CY2022	fact	Partial Reversal Of Transaction Costs PartialReversalOfTransactionCosts	271687	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	8784563	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	3018750	usd
CY2022	fact	Investments Held In Trust Account Net InvestmentsHeldInTrustAccountNet	349927313	usd
CY2022	fact	Warrant Liabilities Public Warrants WarrantLiabilitiesPublicWarrants	1725000	usd
CY2022Q4	fact	Sale Of Ordinary Shares Redemption SaleOfOrdinarySharesRedemption	34500000	shares
CY2022	fact	Proceeds From Gross Proceeds From Ipo ProceedsFromGrossProceedsFromIPO	345000000	usd
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	10350000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-18600644	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	28950644	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	345000000	usd
CY2022	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	4927313	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	349927313	usd
CY2022	fact	Warrant Liabilities Private Warrants WarrantLiabilitiesPrivateWarrants	1253333	usd
CY2022	fact	Convertible Note Amount ConvertibleNoteAmount	338200	usd
CY2022	fact	Convertible Noteone ConvertibleNoteone	338200	usd
CY2022	fact	Convertible Notes Two ConvertibleNotesTwo	152200	usd
CY2022Q4	fact	Total Warrant Liabilities TotalWarrantLiabilities	3806933	usd
CY2021	fact	Investments Held In Trust Account Us Money Market Fund InvestmentsHeldInTrustAccountUSMoneyMarketFund	484	usd
CY2021	fact	Change In Deferred Underwriting Fee ChangeInDeferredUnderwritingFee		usd
CY2022Q2	fact	Sponsor Share SponsorShare	25000	shares
CY2022Q4	us-gaap	Option Contract Indexed To Equity Settlement Number Of Shares Effect Of Change In Fair Value Of Share OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare	25000	shares
CY2022Q4	us-gaap	Forward Contract Indexed To Equity Settlement Share Fair Value Per Share ForwardContractIndexedToEquitySettlementShareFairValuePerShare	4.95
CY2020Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	300000	usd
CY2022Q4	fact	Working Capital Loans WorkingCapitalLoans	675000	usd
CY2022Q2	fact	Promissiory Note Related Party PromissioryNoteRelatedParty	500000	usd
CY2022Q2	fact	Promissiory Note Related Party PromissioryNoteRelatedParty	500000	usd
CY2022Q4	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	325000	usd
CY2022Q2	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	1.5
CY2022	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	1225000	usd
CY2021	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	0	usd
CY2023Q1	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	2100000	usd
CY2021Q1	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	6405000	usd
CY2021Q1	fact	Deferred Underwriting Discount Per Unit DeferredUnderwritingDiscountPerUnit	0.35
CY2021Q1	fact	Aggregate Gross Proceeds AggregateGrossProceeds	12075000	usd
CY2022	us-gaap	Expense Related To Distribution Or Servicing And Underwriting Fees ExpenseRelatedToDistributionOrServicingAndUnderwritingFees	9056250	usd
CY2022	fact	Partial Reversal Of Transaction Costs PartialReversalOfTransactionCosts	271687	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	8784563	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	3018750	usd
CY2022	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	100000000	usd
CY2022	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	10000000	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q4	fact	Ordinary Shares Description OrdinarySharesDescription	the Sponsor paid $25,000, or approximately $0.003 per share, to cover certain offering costs in consideration for 7,187,500 Class B ordinary shares, par value $0.0001 per share. On February 25, 2021, the Company effected a share dividend whereby the Company issued 1,437,500 Class B ordinary shares, resulting in an aggregate of 8,625,000 Class B ordinary shares outstanding. All share and per-share amounts have been retroactively restated to reflect the share dividend.
CY2022	fact	Total Number Of Ordinary Shares Outstanding Percentage TotalNumberOfOrdinarySharesOutstandingPercentage	0.20	pure
CY2022	fact	Warrant Expiration Term WarrantExpirationTerm	P5Y
CY2022	fact	Investments Held In Trust Account Us Treasure Securities InvestmentsHeldInTrustAccountUSTreasureSecurities	349927313	usd
CY2021	fact	Investments Held In Trust Account Us Treasure Securities InvestmentsHeldInTrustAccountUSTreasureSecurities	345105197	usd
CY2021	fact	Investments Held In Trust Account Net InvestmentsHeldInTrustAccountNet	345105681	usd
CY2021	fact	Warrant Liabilities Public Warrants WarrantLiabilitiesPublicWarrants	4916250	usd
CY2021	fact	Warrant Liabilities Private Warrants WarrantLiabilitiesPrivateWarrants	3572000	usd
CY2021Q4	fact	Total Warrant Liabilities TotalWarrantLiabilities	8488250	usd
CY2022Q4	us-gaap	Share Price SharePrice	10.1
CY2021Q4	us-gaap	Share Price SharePrice	9.68
CY2022Q4	fact	Fair Value Measurement Strike Price FairValueMeasurementStrikePrice	11.5
CY2021Q4	fact	Fair Value Measurement Strike Price FairValueMeasurementStrikePrice	11.5
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P0Y4M17D
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P0Y6M
CY2022	fact	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rates ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates	de minimis
CY2021	fact	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rates ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates	10.50%
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0398	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.013	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	fact	Fair Value Warrant Liabilities FairValueWarrantLiabilities	5509917	usd
CY2021	fact	Fair Value Warrant Liabilities FairValueWarrantLiabilities	9381750	usd
CY2021	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1		usd
CY2022	us-gaap	Noninterest Expense Offering Cost NoninterestExpenseOfferingCost		usd
CY2021	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1		usd
CY2022	fact	Offering Costs Allocated To Warrants OfferingCostsAllocatedToWarrants		usd
CY2022	fact	Cash Deposited In Trust Account CashDepositedInTrustAccount		usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
CY2022	fact	Initial Value Of Class A Ordinary Share Subject To Possible Redemption InitialValueOfClassAOrdinaryShareSubjectToPossibleRedemption		usd
CY2022	fact	Initial Value Of Warrant Liabilities InitialValueOfWarrantLiabilities		usd
CY2022	fact	Deferred Offering Costs Included In Accrued Expenses DeferredOfferingCostsIncludedInAccruedExpenses		usd
CY2022	fact	Deferred Offering Costs Paid Under Promissory Note DeferredOfferingCostsPaidUnderPromissoryNote		usd
CY2021	fact	Gross Unrealized Gain GrossUnrealizedGain		usd
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001838987

Files In Submission

Name	View Source	Status
0001213900-23-027997-index-headers.html	Edgar Link	pending
0001213900-23-027997-index.html	Edgar Link	pending
0001213900-23-027997.txt	Edgar Link	pending
0001213900-23-027997-xbrl.zip	Edgar Link	pending
f10k2022ex31-1_freedomacq1.htm	Edgar Link	pending
f10k2022ex31-2_freedomacq1.htm	Edgar Link	pending
f10k2022ex32-1_freedomacq1.htm	Edgar Link	pending
f10k2022ex32-2_freedomacq1.htm	Edgar Link	pending
f10k2022ex4-1_freedomacq1.htm	Edgar Link	pending
f10k2022_freedomacq1.htm	Edgar Link	pending
fact-20221231.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fact-20221231_lab.xml	Edgar Link	unprocessable
fact-20221231_pre.xml	Edgar Link	unprocessable
fact-20221231_cal.xml	Edgar Link	unprocessable
fact-20221231_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f10k2022_freedomacq1_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CSLR
Complete Solaria, Inc. Stock $cslr

2022 Q4 Form 10-K Financial Statement

#000121390023027997 Filed on April 06, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CSLR Complete Solaria, Inc. Stock $cslr

2022 Q4 Form 10-K Financial Statement

#000121390023027997 Filed on April 06, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CSLR
Complete Solaria, Inc. Stock $cslr